Skip to content

Drug interactions

Imatinib + Rivaroxaban

Severity: Moderate

Imatinib and Rivaroxaban: moderate interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Imatinib can cause thrombocytopenia and bleeding, which adds to the hemorrhagic risk of rivaroxaban. Imatinib is also a CYP3A4 inhibitor and may modestly raise rivaroxaban exposure.

What this interaction means in plain words

Imatinib and Rivaroxaban can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.

Imatinib belongs to Oncology; Rivaroxaban belongs to Cardiovascular.

Evidence level: Low

Why it happens

Additive bleeding risk from imatinib thrombocytopenia plus anticoagulation, with possible weak CYP3A4 and P-gp inhibition increasing rivaroxaban levels.

What to do

Monitor platelet counts and signs of bleeding during combined use. Hold or reduce anticoagulation if marked thrombocytopenia develops.

What to ask your pharmacist

  • Should I take them at different times of day?
  • Does the dose of either medicine need to change?
  • Is there anything I should avoid, such as alcohol or certain foods, while on both?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Imatinib and Rivaroxaban, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 14 days on the web. No card needed.

Frequently asked questions

Can I take Imatinib with Rivaroxaban?

MediHelp rates the interaction as moderate. Imatinib and Rivaroxaban can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Imatinib can cause thrombocytopenia and bleeding, which adds to the hemorrhagic risk of rivaroxaban. Imatinib is also a CYP3A4 inhibitor and may modestly raise rivaroxaban exposure.

How serious is the interaction between Imatinib and Rivaroxaban?

MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor platelet counts and signs of bleeding during combined use. Hold or reduce anticoagulation if marked thrombocytopenia develops.

What other medicines interact with Rivaroxaban?

MediHelp also lists interactions of Rivaroxaban with, for example, Defibrotide, Ketoconazole, Ketorolac. The full list is on the Rivaroxaban page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in